Vaxxas is a clinical‑stage biotechnology company commercializing HD‑MAP, a needle‑free vaccine delivery system. Instead of conventional needles, HD‑MAP uses tiny projections coated with dried vaccine, applied to the skin via a small patch and applicator. This innovation delivers the vaccine directly to immune cells just beneath the skin, triggering